back to archive


21.09.2020 - 24.09.2020



More information and registration at:


The 20th Annual Biotech in Europe Forum is recognised as the leading international stage for those interested in investing and partnering in the biotech and life science industry. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners.

Under current circumstances including travel restrictions we have decided that for the first time #Sachs_BEF will be held in a digital format. This will allow us to support our community and past attendees. We will provide both the usual stimulating programme and the networking opportunities through the video online meeting system. We expect most of our past attendees to participate and all our sponsors Gold Sponsor: LifeSci Advisors; Silver Sponsors: BeiGene, Torreya Partners LLP; Bronze Sponsor: Euronext Paris S.A.; Contributing Sponsor: BioMedPartners AG, Novo Holdings A/S have agreed to support the digital event. The 8th Annual HealthTech Innovation Forum is merged with the 2nd Annual HealthTech CEO Forum, scheduled for March 2nd 2021 at Hilton Zurich.

The Digital 20th Annual BEF is going to take place on the 21st -24th of September with main programme being spread throughout 4 days and will feature more than five hours each day of high-level speeches and panel discussions. In addition, there is a global company showcase of 50+ presentations by corporates, offering innovative solutions and looking for capital and partnerships. We estimate 700+ registered on the portal and watching part/all sessions and at least same amount of views from videos on demand after the event. Meetings will take place from September 21st to 25th and from September 28th to October 2nd. Moreover, the system will be open for 12 hours a day and we expect over 2000 meetings completed over 10 days.​ The digital event will consist of:

Day 1: Bio-Pharma & HealthTech: Pandemic Response Day

  • Industry Leaders Response Session
  • Vaccines Panel & Showcase
  • Therapeutic Strategies to Prevent & Treat Covid-19 Panel & Showcase
  • Point of Care Diagnostics Panel

Day 2: BioTech & HealthTech Capital Investment Day

  • Bio-Pharma in a New Era Panel
  • Accessing US Capital Markets from Europe Panel
  • IPO BootCamp
  • Revolution in Cell Based Therapies Across Therapeutics Panel & Showcase
  • VC & Private Equity: Addressing All Opportunities, Including Crossover Transactions Panel & Showcase
  • Early Stage Investment Panel

Day 3: Bio-Pharma Partnering & Therapeutics Day

  • Pharma DealMaking Panel
  • Immuno-Oncology BD&L Panel & Showcase
  • Advanced Therapies in Immuno-Oncology Panel & Showcase
  • Krakow and Małopolska Region of Poland – Life Science is Growing Here Panel
  • Platform Technologies & Novel Therapeutics Panel & Showcase

Day 4: Neuroscience Investor Day

  • CNS Partnering & DealMaking Panel & Showcase
  • Progress in AD & PD Panel & Showcase
  • Advanced Therapeutics Panel & Showcase
  • Industry & Investor Roundtable

Confirmed Keynote Speakers Include:

  • Harry Tracy, President, NI Research Inc.
  • Peter Kolchinsky, Managing Director, RA Capital Management, LLC
  • More TBA...